Overall, our data show that BCYRN1 can enhance TM4SF1 expression in a BATF recruitment-dependent fashion to modulate tumor malignancy, thereby enhancing HCC cell migration, invasion, and proliferation. This evidence concerns the gene BATF and hepatocellular carcinoma.